Literature DB >> 10329452

Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells.

M Takemoto1, K Yokote, M Yamazaki, A L Ridall, W T Butler, T Matsumoto, K Tamura, Y Saito, S Mori.   

Abstract

Atherosclerotic vascular disease is a major complication of diabetic patients, and osteopontin has recently been implicated in the development of atherosclerosis. In the present study, we have investigated the effects of high glucose on expression of osteopontin in cultured rat aortic smooth muscle cells. High concentrations of glucose increased osteopontin secretion from the cells, and the increased secretion was completely inhibited by an inhibitor of protein kinase C, GF109203X. Northern blot analysis confirmed the enhanced effect of glucose on expression of osteopontin mRNA. Promoter activity of osteopontin, measured using the osteopontin promoter/luciferase expression vector system, was increased by high glucose, and the enhanced effect was completely inhibited by GF109203X. Glucosamine also increased the promoter activity of osteopontin, and azaserine, an inhibitor of glutamine:fructose-6-phosphate amidotransferase (the key enzyme of the hexosamine pathway), profoundly inhibited high glucose-mediated increase in the promoter activity. Taken together, these data indicate that high glucose enhances the expression of osteopontin at the transcriptional level possibly through the activation of protein kinase C as well as the hexosamine pathway. Our results suggest that osteopontin could play a role in the development of diabetic vascular complications. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329452     DOI: 10.1006/bbrc.1999.0701

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells.

Authors:  M Takemoto; M Kitahara; K Yokote; S Asaumi; A Take; Y Saito; S Mori
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue.

Authors:  F Jahns; A Wilhelm; N Jablonowski; H Mothes; Mariya Radeva; A Wölfert; K O Greulich; M Glei
Journal:  Carcinogenesis       Date:  2011-03-31       Impact factor: 4.944

Review 3.  G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling.

Authors:  Bengt-Olof Nilsson; Björn Olde; L M Fredrik Leeb-Lundberg
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 4.  Arterial calcification in diabetes.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

5.  Diabetes and Abdominal Aortic Calcification-a Systematic Review.

Authors:  Emilie Frey Bendix; Eskild Johansen; Thomas Ringgaard; Martin Wolder; Jakob Starup-Linde
Journal:  Curr Osteoporos Rep       Date:  2018-02       Impact factor: 5.096

Review 6.  Coronary calcium screening and coronary risk stratification.

Authors:  Paolo Raggi; George James
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

Review 7.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04

8.  Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Xiaoxiang Yan; Motoaki Sano; Lin Lu; Wei Wang; Qi Zhang; Ruiyan Zhang; Lingjie Wang; Qiujing Chen; Keiichi Fukuda; Weifeng Shen
Journal:  Cardiovasc Diabetol       Date:  2010-10-29       Impact factor: 9.951

9.  Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy.

Authors:  Tomoaki Nagao; Takafumi Okura; Jun Irita; Masanori Jotoku; Daijiro Enomoto; Veena Rasika Desilva; Ken-Ichi Miyoshi; Mie Kurata; Yutaka Matsui; Toshimitsu Uede; Jitsuo Higaki
Journal:  Nephron Extra       Date:  2012-03-29

Review 10.  The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification.

Authors:  Amber M Kay; C LaShan Simpson; James A Stewart
Journal:  J Diabetes Res       Date:  2016-07-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.